DanCann Pharma A/S Logo

DanCann Pharma A/S

DANCAN | SPGR

Overview

Corporate Details

ISIN(s):
DK0061410487
LEI:
549300KLXQ6IC2YUUB58
Country:
Denmark
Address:
Rugvænget 5, 6823 Ansager
Sector:
Health Care
Industry:
Pharmaceuticals

Description

DanCann Pharma was founded in 2018 and is a Danish pharmaceutical company. DanCann Pharma focuses on discovering, developing, manufacturing, and commercializing cannabinoid therapeutics in a broad range of disease areas. The company makes prescription (Rx-pharmaceuticals) and over-the-counter (OTC) pharmaceuticals mainly focused on pain patients with alternative needs and management to handle their illness, covered by the Danish Pilot Programme for medical cannabis.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hamlet BioPharma AB Logo Hamlet BioPharma AB Sweden HAMLET
Harm Reduction Group AB Logo Harm Reduction Group AB Sweden NOHARM
Heidelberg Pharma AG Logo Heidelberg Pharma AG Germany HPHA
HELLENIC DYNAMICS PLC Logo HELLENIC DYNAMICS PLC United Kingdom HELD
HIKMA Pharmaceuticals PLC Logo HIKMA Pharmaceuticals PLC United Kingdom HIK
H. Lundbeck A Logo H. Lundbeck A Denmark HLUN
Hod-Assaf Industries Ltd. Logo Hod-Assaf Industries Ltd. Israel HOD
HUDDLED GROUP PLC Logo HUDDLED GROUP PLC United Kingdom HUD
Iconovo AB Logo Iconovo AB Sweden ICO
iDNA Genomics Public Ltd Logo iDNA Genomics Public Ltd Cyprus IDNA